Metabomed is developing a therapeutic strategy based on new drugs that inhibit metabolic enzymes which are vital for cancer cells’ survival
Location: Israel, Center District, Yavne
Employees: 11-50
Founded date: 2013
Investors 2
Date | Name | Website |
08.11.2022 | M Ventures | m-ventures... |
- | Pontifax V... | pontifax.c... |
Mentions in press and media 3
Date | Title | Description | Source |
09.09.2020 | MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Off... | CAMBRIDGE, Mass. and YAVNE, Israel, Sept. 9, 2020 /PRNewswire/ -- MetaboMed, a biopharmaceutical com... | marketscre... |
19.12.2019 | Metabomed Completes a $12.5 Million Raise | Metabomed, a leading cancer metabolism company completed a financing of $12.5 million bringing the t... | citybizlis... |
04.04.2016 | Metabomed Raises $18M in Series A Funding | Metabomed Ltd, a Yavne, Israel-based cancer metabolism company, completed an extension of its Series... | finsmes.co... |